Alterations in expression of major histocompatibility complex (MHC) antigens on tumor cells clearly correlate with the tumorgenicity and metastatic potential of those cells. These changes in the biological behavior of the tumor cells are presumably secondary to resulting changes in their susceptibil
Induction of major histocompatibility class I antigens by interferons in undifferentiated F9 cells
β Scribed by Yu-Jui Yvonne Wan; Bonnie M. Orrison; Ronald Lieberman; Philip Lazarovici; Keiko Ozato
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 965 KB
- Volume
- 130
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
β¦ Synopsis
Mouse embryonal carcinoma F9 cells, upon treatment with interferons (IFNs), express major histocompatibility (MHC) Class I antigens, which are otherwise not expressed in these cells. Both I F N y and IFN-aIP increase the steady-state level of Class I mRNA within 60 min of the treatment which leads to the subsequent surface expression of the H-2Kb and H-2Db antigens, suggesting that undifferentiated F9 cells express IFN receptors. IFNs induce Class I antigen expression in F9 cells in a highly selective manner: unlike retinoic acid treatment which also stimulates the antigen expression, IFNs induce neither morphological differentiation, increased binding of epidermal growth factor, nor reduction of expression of stage specific embryonic antigen. The effect of IFNs is reversible; removal of IFNs, even after prolonged exposures, results in a rapid loss of the Class I gene expression. Further, Class I mRNA induction is not inhibited by cycloheximide, suggesting possible independence from de novo protein synthesis. This Class I antigen induction in F9 cells is reminiscent of that observed in somite stage mouse embryos by IFN treatment and may offer a model system to study activation of MHC genes during development.
π SIMILAR VOLUMES
## Abstract Surface expression of the majority of class I major histocompatibility complex (MHC) heavy chains is known to require assembly with Ξ²~2~ microglobulin (Ξ²~2~m). To define other factors involved in class I MHC assembly, we have studied two tumor cell lines that are deficient in cell surfa
## Abstract The identification of endogenously produced antigenic peptides presented by MHC class I molecules has opened the way to peptideβbased strategies for CTL induction __in vivo__. Here we demonstrate that the induction __in vivo__ of CTL directed against naturally processed antigens can be